These findings suggest that the presence of NASH reduces adiponectin production, which in turn decreases the anti-inflammatory effect of adiponectin, resulting in exacerbated psoriatic skin changes, at least partially, by directly acting on epidermal keratinocytes. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.